Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
Top Sells
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$260M |
| 2 |
Y
Alleghany Corporation
Y
|
+$139M |
| 3 |
FBC
Flagstar Bancorp, Inc. New
FBC
|
+$137M |
| 4 |
NLSN
Nielsen Holdings plc
NLSN
|
+$121M |
| 5 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$86.4M |
Sector Composition
| 1 | Financials | 15.11% |
| 2 | Technology | 12.49% |
| 3 | Industrials | 10.78% |
| 4 | Healthcare | 9.96% |
| 5 | Consumer Discretionary | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Day One Biopharmaceuticals
DAWN
$741M
| $2.98K | ﹤0.01% |
138,608
+87,200
| +170% | +$1.88K |
|
2602
Confluent
CFLT
$6.75B
| $2.98K | ﹤0.01% |
133,860
+41,329
| +45% | +$919 |
|
2603
Vista Energy
VIST
$3.86B
| $2.97K | ﹤0.01% |
189,770
| – | – |
|
2604
Procore
PCOR
$10.6B
| $2.96K | ﹤0.01% |
62,843
+4,652
| +8% | +$219 |
|
|
BZUN
2605
Baozun
BZUN
$268M
| $2.96K | ﹤0.01% |
559,150
-6,323
| -1% | -$33 |
|
2606
Rimini Street
RMNI
$427M
| $2.93K | ﹤0.01% |
769,724
-68,321
| -8% | -$260 |
|
2607
Tarsus Pharmaceuticals
TARS
$2.16B
| $2.93K | ﹤0.01% |
199,676
+57,469
| +40% | +$842 |
|
2608
Altimmune
ALT
$323M
| $2.93K | ﹤0.01% |
177,865
+3,492
| +2% | +$57 |
|
2609
LoveSac
LOVE
$248M
| $2.91K | ﹤0.01% |
132,394
-66,774
| -34% | -$1.47K |
|
2610
Privia Health
PRVA
$2.79B
| $2.91K | ﹤0.01% |
+128,281
| New | +$2.91K |
|
2611
Atara Biotherapeutics
ATRA
$82.9M
| $2.91K | ﹤0.01% |
35,527
+10,848
| +44% | +$889 |
|
2612
The Honest Company
HNST
$437M
| $2.91K | ﹤0.01% |
966,266
+706,730
| +272% | +$2.13K |
|
2613
Repay Holdings
RPAY
$503M
| $2.91K | ﹤0.01% |
360,873
+110,790
| +44% | +$892 |
|
|
OMCC
2614
Old Market Capital Corporation Common Stock
OMCC
$35.4M
| $2.9K | ﹤0.01% |
459,121
-5,479
| -1% | -$35 |
|
2615
Kewaunee Scientific
KEQU
$133M
| $2.89K | ﹤0.01% |
186,049
+60
| +0% | +$1 |
|
2616
Remitly
RELY
$3.82B
| $2.88K | ﹤0.01% |
+251,441
| New | +$2.88K |
|
|
CAMP
2617
DELISTED
CalAmp Corp.
CAMP
| $2.87K | ﹤0.01% |
27,855
-4,710
| -14% | -$485 |
|
2618
Mersana Therapeutics
MRSN
$36.6M
| $2.87K | ﹤0.01% |
19,591
-109
| -0.6% | -$16 |
|
|
ONC
2619
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.5B
| $2.85K | ﹤0.01% |
12,953
-1,362
| -10% | -$300 |
|
2620
ARS Pharmaceuticals
SPRY
$996M
| $2.85K | ﹤0.01% |
334,093
+3,359
| +1% | +$29 |
|
2621
Vertex
VERX
$3.84B
| $2.84K | ﹤0.01% |
195,439
+9,614
| +5% | +$140 |
|
2622
Farmer Brothers
FARM
$41.4M
| $2.83K | ﹤0.01% |
614,767
+43,981
| +8% | +$203 |
|
2623
Embotelladora Andina Series B
AKO.B
$3.85B
| $2.83K | ﹤0.01% |
195,027
+2,977
| +2% | +$43 |
|
2624
Fulcrum Therapeutics
FULC
$376M
| $2.82K | ﹤0.01% |
386,832
+152,752
| +65% | +$1.11K |
|
2625
Q2 Holdings
QTWO
$5.15B
| $2.81K | ﹤0.01% |
104,463
+30,969
| +42% | +$832 |
|